Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.580
-0.100 (-5.95%)
At close: Jan 20, 2026, 4:00 PM EST
1.710
+0.130 (8.23%)
After-hours: Jan 20, 2026, 7:57 PM EST
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $197.85 million as of January 20, 2026. Its market cap has increased by 160.52% in one year.
Market Cap
197.85M
Enterprise Value
190.71M
1-Year Change
160.52%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has increased from $145.96M to $197.85M, an increase of 35.55%. That is a compound annual growth rate of 7.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 210.38M | 18.82% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | 145.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |